Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and interleukin 12 in vaccination against spontaneous tumor development in proto-neu transgenic mice

Cancer Research

Volumn 60, Issue 14, 2000, Pages 3777-3781

  Sfondrini, Lucia ^a   Rodolfo, Monica ^a   Singh, Mahavir ^a   Colombo, Mario P ^a   Colnaghi, Maria I ^a   Mènard, Sylvie ^b   Balsari, Andrea ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BREAST CANCER; CANCER IMMUNIZATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; GENETIC TRANSDUCTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC MOUSE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AGE FACTORS; ANIMALS; ANTIGENS, BACTERIAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER VACCINES; CELL DIVISION; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LIPOPROTEINS; LYMPH NODES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; RATS; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; SPLEEN; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034660873     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gene transfer as cancer therapy
2. Combined vaccination with major histocompatibility class 1 and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases
3. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
4. Tolerance, danger, and the extended family
5. Induction of TH1 and TH2 immunity in neonatal mice
6. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. 1. Isolation, physicochemical characterization, and antitumor activity
7. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA
8. Tuberculosis and cancer: Parallels in host responses and therapeutic approaches?
9. Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38 kDa antigen
10. High level antibody response to retrovirus-associated but not to melanocyte lineage-specific antigens in mice protected from B16 melanoma
11. The advent of the "unpatients,"
12. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
13. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice
14. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge
15. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells
16. Systemic administration of rIL-12 synergistically enhances the therapeutic effect of a TNF gene-transduced cancer vaccine
17. Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression
18. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
19. CpG oligodeoxynucleotides act as adjuvants that switch on T helper I (Thl) immunity
20. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
21. Recycling MHC class I molecules and endosomal peptide loading
22. Cytotoxic T lymphocyte activation by cross-priming
23. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
24. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection
25. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
26. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite
27. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
28. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines
29. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice
30. B7-1 and interleukin 12 synergistically induce effective antitumor immunity
31. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors